Cargando…

Dry eye disease and meibomian gland dysfunction among a clinical sample of type 2 diabetes patients in Ghana

OBJECTIVE: To evaluate dry eye disease and meibomian gland dysfunction among type 2 diabetes patients METHODS: A hospital-based cross-sectional study was conducted. Parameters assessed included meibum expressibility and quality, Schirmer test 1, tear breakup time (TBUT), ocular surface staining, bli...

Descripción completa

Detalles Bibliográficos
Autores principales: Abu, Emmanuel K, Ofori, Amanfo O, Boadi-Kusi, Samuel B, Ocansey, Stephen, Yankah, Richard K, Kyei, Samuel, Awuku, Asante Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Makerere Medical School 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382471/
https://www.ncbi.nlm.nih.gov/pubmed/36032480
http://dx.doi.org/10.4314/ahs.v22i1.36
_version_ 1784769287237402624
author Abu, Emmanuel K
Ofori, Amanfo O
Boadi-Kusi, Samuel B
Ocansey, Stephen
Yankah, Richard K
Kyei, Samuel
Awuku, Asante Y
author_facet Abu, Emmanuel K
Ofori, Amanfo O
Boadi-Kusi, Samuel B
Ocansey, Stephen
Yankah, Richard K
Kyei, Samuel
Awuku, Asante Y
author_sort Abu, Emmanuel K
collection PubMed
description OBJECTIVE: To evaluate dry eye disease and meibomian gland dysfunction among type 2 diabetes patients METHODS: A hospital-based cross-sectional study was conducted. Parameters assessed included meibum expressibility and quality, Schirmer test 1, tear breakup time (TBUT), ocular surface staining, blink rates and Ocular Surface Disease Index (OSDI) scores. Dry eye was diagnosed based on a combination of subjective symptoms, tear function and ocular surface staining. RESULTS: Prevalence of DED and MGD were 72.3% and 55.3% respectively. Symptomatic dry eye (OSDI scores) was significantly associated with duration of diabetes (rs = 0.11, P = 0.028) and the presence of conjunctival disorders (OR = 2.09, P = 0.002). MGD was a risk factor for DED (OR = 1.99, P = 0.008); ocular surface damage, the presence of eye lid lesions, abnormal Schirmer test and reduced TBUT were significantly associated with MGD, the strongest predictor being ocular surface damage (OR = 3.21, P = 0.001). OSDI scores had no association with the presence of corneal lesions possibly due to reduced corneal sensitivity. CONCLUSION: DED and MGD were prevalent among the patients and therefore there is the need for dry eye assessment as a routine clinical management protocol for patients with type 2 diabetes.
format Online
Article
Text
id pubmed-9382471
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Makerere Medical School
record_format MEDLINE/PubMed
spelling pubmed-93824712022-08-25 Dry eye disease and meibomian gland dysfunction among a clinical sample of type 2 diabetes patients in Ghana Abu, Emmanuel K Ofori, Amanfo O Boadi-Kusi, Samuel B Ocansey, Stephen Yankah, Richard K Kyei, Samuel Awuku, Asante Y Afr Health Sci Articles OBJECTIVE: To evaluate dry eye disease and meibomian gland dysfunction among type 2 diabetes patients METHODS: A hospital-based cross-sectional study was conducted. Parameters assessed included meibum expressibility and quality, Schirmer test 1, tear breakup time (TBUT), ocular surface staining, blink rates and Ocular Surface Disease Index (OSDI) scores. Dry eye was diagnosed based on a combination of subjective symptoms, tear function and ocular surface staining. RESULTS: Prevalence of DED and MGD were 72.3% and 55.3% respectively. Symptomatic dry eye (OSDI scores) was significantly associated with duration of diabetes (rs = 0.11, P = 0.028) and the presence of conjunctival disorders (OR = 2.09, P = 0.002). MGD was a risk factor for DED (OR = 1.99, P = 0.008); ocular surface damage, the presence of eye lid lesions, abnormal Schirmer test and reduced TBUT were significantly associated with MGD, the strongest predictor being ocular surface damage (OR = 3.21, P = 0.001). OSDI scores had no association with the presence of corneal lesions possibly due to reduced corneal sensitivity. CONCLUSION: DED and MGD were prevalent among the patients and therefore there is the need for dry eye assessment as a routine clinical management protocol for patients with type 2 diabetes. Makerere Medical School 2022-03 /pmc/articles/PMC9382471/ /pubmed/36032480 http://dx.doi.org/10.4314/ahs.v22i1.36 Text en © 2022 Abu EK et al. https://creativecommons.org/licenses/by/4.0/Licensee African Health Sciences. This is an Open Access article distributed under the terms of the Creative commons Attribution License (https://creativecommons.org/licenses/BY/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Articles
Abu, Emmanuel K
Ofori, Amanfo O
Boadi-Kusi, Samuel B
Ocansey, Stephen
Yankah, Richard K
Kyei, Samuel
Awuku, Asante Y
Dry eye disease and meibomian gland dysfunction among a clinical sample of type 2 diabetes patients in Ghana
title Dry eye disease and meibomian gland dysfunction among a clinical sample of type 2 diabetes patients in Ghana
title_full Dry eye disease and meibomian gland dysfunction among a clinical sample of type 2 diabetes patients in Ghana
title_fullStr Dry eye disease and meibomian gland dysfunction among a clinical sample of type 2 diabetes patients in Ghana
title_full_unstemmed Dry eye disease and meibomian gland dysfunction among a clinical sample of type 2 diabetes patients in Ghana
title_short Dry eye disease and meibomian gland dysfunction among a clinical sample of type 2 diabetes patients in Ghana
title_sort dry eye disease and meibomian gland dysfunction among a clinical sample of type 2 diabetes patients in ghana
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382471/
https://www.ncbi.nlm.nih.gov/pubmed/36032480
http://dx.doi.org/10.4314/ahs.v22i1.36
work_keys_str_mv AT abuemmanuelk dryeyediseaseandmeibomianglanddysfunctionamongaclinicalsampleoftype2diabetespatientsinghana
AT oforiamanfoo dryeyediseaseandmeibomianglanddysfunctionamongaclinicalsampleoftype2diabetespatientsinghana
AT boadikusisamuelb dryeyediseaseandmeibomianglanddysfunctionamongaclinicalsampleoftype2diabetespatientsinghana
AT ocanseystephen dryeyediseaseandmeibomianglanddysfunctionamongaclinicalsampleoftype2diabetespatientsinghana
AT yankahrichardk dryeyediseaseandmeibomianglanddysfunctionamongaclinicalsampleoftype2diabetespatientsinghana
AT kyeisamuel dryeyediseaseandmeibomianglanddysfunctionamongaclinicalsampleoftype2diabetespatientsinghana
AT awukuasantey dryeyediseaseandmeibomianglanddysfunctionamongaclinicalsampleoftype2diabetespatientsinghana